Temasek-led Investor Group In Us$250 Million Vaccine Bet On Biontech - Cna

by channelnewsasia.com posted 8months ago 26 views
BioNTech said Singapore's Temasek and other investors are injecting US$250 million into the German biotech firm through a private placement, reflecting heightened investor appetite for promising developers' vaccines against the coronavirus.

In this article